Skip to content
Lower risk Medical device recall · FDA · Published July 19, 2019

Aniara Diagnostica ZYMUTEST HIA MonoStrip Kit Recall: Residual Crystallization Risk

Aniara Diagnostica recalls ZYMUTEST HIA MonoStrip IgG ELISA kits (Model RK041A) due to residual crystallization causing negative controls to go out of range. Affected kits sold under specific serial numbers.

🇺🇸 FDA recall #Z-2346-2019Medical deviceAniara Diagnostica ›
Take action

Contact the company

Recalling firmAniara Diagnostica LLC7768 Service Center Dr · West Chester, OH 45069-2442
✎ GovInfoNow plain-language explainer

What happened, in plain English

Ani: Aniara Diagnostica is recalling ZYMUTEST HIA MonoStrip IgG ELISA kits (Model RK041A) because residual crystallization in the microplate can cause negative controls to show out of range results. This could lead to inaccurate test outcomes. Read more at govinfonow.com/recall/67380-aniara-diagnostica-zymutest-hia-monostrip-kit-recall-residual-crystallization-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/67380-aniara-diagnostica-zymutest-hia-monostrip-kit-recall-residual-crystallization-risk · Updated August 19, 2026 · FDA enforcement record: FDA #Z-2346-2019

Cite this page

“Aniara Diagnostica ZYMUTEST HIA MonoStrip Kit Recall: Residual Crystallization Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/67380-aniara-diagnostica-zymutest-hia-monostrip-kit-recall-residual-crystallization-risk. Based on FDA recall #Z-2346-2019 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2346-2019%22&limit=1).

Why it’s dangerous

Residual crystallization in the microplate can cause negative controls to show out of range results. This may lead to inaccurate test outcomes, potentially affecting diagnostic accuracy.

Who’s affected

Users of the ZYMUTEST HIA MonoStrip IgG ELISA kit (Model RK041A) for in vitro diagnostics are affected. Laboratory personnel and healthcare providers using this specific kit are most at risk.

How to tell if you have this one

Check for the model number RK041A on the kit packaging. Affected kits were sold with serial numbers F1701084 or F1900611.

  • Brand
    Aniara Diagnostica
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Distribution to US states of NC, NH, NY, and OH, and Sweden.
Recall numberProduct, codes & lotsQuantity
Z-2346-2019ZYMUTEST HIA MonoStrip, IgG ELISA kit, Model No. RK041A, for in vitro diagnostic use.; F1701084, F190061151
Z-2347-2019ZYMUTEST HIA MonoStrip, IgGAM ELISA kit, Model No. RK041D, for in vitro diagnostic use.; F170157146
Based on the official FDA remedy

What to do — step by step

  1. Check Kit Serial Numbers

    Verify if your kit has serial numbers F1701084 or F1900611.

Where it went and when

Where it was distributed

Distributed in 4 states, and outside the U.S.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: yesNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: yesNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: yesOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: yesNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “Distribution to US states of NC, NH, NY, and OH, and Sweden.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: New Hampshire, New York, North Carolina, Ohio.

Recall timeline

FDA terminated this recall 23 months after the firm started it.

1. Firm started the recall: Jul 19, 201912. FDA classified it Class II: Aug 22, 201923. Published in FDA’s Enforcement Report: Aug 28, 201934. FDA terminated the recall: Jun 11, 2021420192021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2346-2019 (July 19, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2346-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA